Trial · NCT07910500
Anterior Nerves of the Knee Block Versus Femoral Nerve Block for Knee Arthroscopy
NCT07910500, Not applicable, Recruiting, Van Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Anterior Nerves of the Knee Block Versus Femoral Nerve Block for Knee Arthroscopy. Trials, record NCT07910500. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910500
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Anterior Nerves of the Knee Block Versus Femoral Nerve Block for Knee Arthroscopy
- NCT number
- NCT07910500
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 70 participants, estimated
- Lead sponsor
- Van Training and Research Hospital
- Conditions
- Postoperative Pain, Knee Arthroscopy, Analgesia
- Interventions
- Anterior Nerves of the Knee (ANK) Block, Femoral Nerve Block
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Postoperative Tramadol Consumption | 24 hours after surgery | Total amount of intravenous tramadol (mg) administered as rescue analgesia during the first 24 hours after the end of surgery. |
| Primary | Pain Score at Rest | 0, 2, 4, 6, 12 and 24 hours after surgery | Pain intensity at rest assessed with a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst imaginable pain) by an assessor blinded to group allocation. |
| Primary | Pain Score on Movement | 0, 2, 4, 6, 12 and 24 hours after surgery | Pain intensity on movement assessed with a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst imaginable pain) by an assessor blinded to group allocation. |
| Secondary | Time to First Rescue Analgesic | 24 hours after surgery | Time (minutes) from the end of surgery to the first administration of a rescue analgesic (tramadol or paracetamol, whichever is first). Patients who require no analgesic are censored at 24 hours. |
| Secondary | Total Postoperative Paracetamol Consumption | 24 hours after surgery | Total amount of intravenous paracetamol (mg) administered during the first 24 hours after the end of surgery. |
| Secondary | Intraoperative Heart Rate | From baseline (before spinal anesthesia) to the end of surgery | Heart rate (beats/min) recorded at baseline (before spinal anesthesia), skin incision, tourniquet inflation, tourniquet deflation and end of surgery. |
| Secondary | Intraoperative Mean Arterial Pressure | From baseline (before spinal anesthesia) to the end of surgery | Mean arterial pressure (mmHg) recorded at baseline (before spinal anesthesia), skin incision, tourniquet inflation, tourniquet deflation and end of surgery. |
| Secondary | Time to First Mobilization | Up to 48 hours after surgery | Time (hours) from the end of surgery to the first safe ambulation. |
| Secondary | Quadriceps Muscle Strength | 20 minutes after block | Quadriceps muscle strength of the operated limb assessed with the Medical Research Council (MRC) scale from 0 (no contraction) to 5 (normal strength). |
| Secondary | Incidence of Block-Related Complications | 24 hours after surgery | Number of participants with local anesthetic systemic toxicity, hematoma or infection at the injection site, or falls/knee buckling during mobilization. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910500
GET https://conductscience.org/api/trials/v1/NCT07910500/registered